BRISTOL, TN / ACCESS Newswire / October 7, 2025 / Quantum BioPharma Ltd. (QNTM)(FRA:0K91) is quietly redrawing the boundaries of what a biotechnology company can be. The company has evolved beyond ...
Successful completion supports expansion of its ongoing NEXICART-1 (NCT04720313) NXC-201 CAR-T clinical trial to the U.S. NXC-201 is manufactured at our state-of-the-art cellular immunotherapy ...
CDMOs are expanding to provide integrated services, enhancing outsourcing appeal. Sustainability mandates boost adoption of advanced systems, and growth is pronounced in excipient innovation and ...
The "Protein Engineering for Pharmaceutical Biotechnology Training Course (Jan 21st - Jan 22nd, 2026)" training has been added to ResearchAndMarkets.com's offering. Enhance your knowledge in protein ...
Setting new standards in responsible innovation, CSL's Broadmeadows facility blends Pharma 4.0™ principles with sustainable design to transform plasma manufacturing Purpose-built to optimise the ...
A profound transformation is taking place in therapeutic discovery, development, and delivery.2026 will be a pivotal year for ...
RICHMOND, Va. (WRIC) — Nadia Tasnim Ahmed, a student at Virginia Commonwealth University (VCU) in Richmond, will soon become the first person in America to have a Ph.D in pharmaceutical engineering.
Biopharma may see a happier year ahead in 2026 than in recent years, according to analysts at William Blair. For one thing, the industry’s top stocks have recovered from lows that stretched into last ...
Expanded its scientific team with the addition of Mark J. Jaroszeski, PhD, a tenured professor in the Department of Medical Engineering at the University of South Florida. Dr. Jaroszeski, who holds a ...
Hosted on MSN
Fabtech Technologies IPO opens for subscription. Check GMP, price band and other details
Fabtech Technologies, a biopharma engineering solutions provider, has launched its IPO on September 29. The Rs 230 crore issue, entirely a fresh issue of 1.21 crore shares, will close on October 1.
Hosted on MSN
Fabtech Technologies IPO Day 1: Check subscription status, GMP, price band and key highlights
Fabtech Technologies, a specialist in biopharma engineering solutions, launched its initial public offering (IPO) on Monday, September 29. Early bidding on the first day saw a modest overall ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results